Spots Global Cancer Trial Database for Resiliency Training for Patients With NF2 Via Videoconferencing With Skype

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Resiliency Training for Patients With NF2 Via Videoconferencing With Skype

Official Title: Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype

Study ID: NCT02811718

Conditions

Neurofibromatosis 2

Interventions

Stress Management Group 1

Stress Management Group 2

Study Description

Brief Summary: The aim of this study is to determine, whether the 3RP is feasible, accepted and efficacious and durable when delivered via Skype to patients with neurofibromatosis type 2 (NF2) who are deaf or have severe hearing loss using Communication Access Realtime Translation (CART) and/or American Sign Language (ASL). This will be a substudy of the IRB-approved protocol #2013P002605. It is the same study except it is looking at a particular sub-population: patients with NF2 who are hard of hearing.

Detailed Description: